159 related articles for article (PubMed ID: 27418265)
1. Development, implementation and outcome analysis of semi-automated alerts for metformin dose adjustment in hospitalized patients with renal impairment.
Niedrig D; Krattinger R; Jödicke A; Gött C; Bucklar G; Russmann S
Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1204-1209. PubMed ID: 27418265
[TBL] [Abstract][Full Text] [Related]
2. Paracetamol overdosing in a tertiary care hospital: implementation and outcome analysis of a preventive alert programme.
Niedrig DF; Bucklar G; Fetzer M; Mächler S; Gött C; Russmann S
J Clin Pharm Ther; 2016 Oct; 41(5):515-8. PubMed ID: 27426404
[TBL] [Abstract][Full Text] [Related]
3. A justification for less restrictive guidelines on the use of metformin in stable chronic renal failure.
Adam WR; O'Brien RC
Diabet Med; 2014 Sep; 31(9):1032-8. PubMed ID: 24909998
[TBL] [Abstract][Full Text] [Related]
4. Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study.
Eppenga WL; Lalmohamed A; Geerts AF; Derijks HJ; Wensing M; Egberts A; De Smet PA; de Vries F
Diabetes Care; 2014 Aug; 37(8):2218-24. PubMed ID: 24842984
[TBL] [Abstract][Full Text] [Related]
5. Do risk factors for lactic acidosis influence dosing of metformin?
Millican S; Cottrell N; Green B
J Clin Pharm Ther; 2004 Oct; 29(5):449-54. PubMed ID: 15482389
[TBL] [Abstract][Full Text] [Related]
6. [Proposal for the modification of metformin use in patients with chronic kidney disease].
Balogh Z; Mátyus J
Orv Hetil; 2012 Sep; 153(39):1527-35. PubMed ID: 23000419
[TBL] [Abstract][Full Text] [Related]
7. Adverse event notifications implicating metformin with lactic acidosis in Australia.
Huang W; Castelino RL; Peterson GM
J Diabetes Complications; 2015; 29(8):1261-5. PubMed ID: 26104729
[TBL] [Abstract][Full Text] [Related]
8. Validity of a clinical decision rule-based alert system for drug dose adjustment in patients with renal failure intended to improve pharmacists' analysis of medication orders in hospitals.
Boussadi A; Caruba T; Karras A; Berdot S; Degoulet P; Durieux P; Sabatier B
Int J Med Inform; 2013 Oct; 82(10):964-72. PubMed ID: 23831104
[TBL] [Abstract][Full Text] [Related]
9. Metformin associated lactic acidosis (MALA): clinical profiling and management.
Moioli A; Maresca B; Manzione A; Napoletano AM; Coclite D; Pirozzi N; Punzo G; Menè P
J Nephrol; 2016 Dec; 29(6):783-789. PubMed ID: 26800971
[TBL] [Abstract][Full Text] [Related]
10. Refining metformin prescribing in New Zealand.
Jayathissa S; Dixon P; Bruce R; Reith D
N Z Med J; 2017 Mar; 130(1452):49-53. PubMed ID: 28337040
[TBL] [Abstract][Full Text] [Related]
11. Metformin induced lactic acidosis--particularities and course.
Strugaru AM; Botnariu G; Agoroaei L; Grigoriu IC; Butnaru E
Rev Med Chir Soc Med Nat Iasi; 2013; 117(4):1035-42. PubMed ID: 24502087
[TBL] [Abstract][Full Text] [Related]
12. Metformin-associated lactic acidosis.
Pasquel FJ; Klein R; Adigweme A; Hinedi Z; Coralli R; Pimentel JL; Umpierrez GE
Am J Med Sci; 2015 Mar; 349(3):263-7. PubMed ID: 24326619
[TBL] [Abstract][Full Text] [Related]
13. [Accumulation of Metformin-associated Lactic Acidosis].
Rüegg T; Caduff B
Dtsch Med Wochenschr; 2017 Mar; 142(6):428-431. PubMed ID: 28329904
[No Abstract] [Full Text] [Related]
14. Metformin-associated lactic acidosis treated with continuous renal replacement therapy.
Alivanis P; Giannikouris I; Paliuras C; Arvanitis A; Volanaki M; Zervos A
Clin Ther; 2006 Mar; 28(3):396-400. PubMed ID: 16750454
[TBL] [Abstract][Full Text] [Related]
15. Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients.
del Pozo-Fernández C; Pardo-Ruiz C; Sánchez-Botella C; Blanes-Castañer V; López-Menchero R; Gisbert-Sellés C; Sánchez-Jodar C; Alvarez-Avellán L
Nefrologia; 2012 May; 32(3):367-73. PubMed ID: 22592422
[TBL] [Abstract][Full Text] [Related]
16. Limitations of metformin use in patients with kidney disease: are they warranted?
Vasisht KP; Chen SC; Peng Y; Bakris GL
Diabetes Obes Metab; 2010 Dec; 12(12):1079-83. PubMed ID: 20977579
[TBL] [Abstract][Full Text] [Related]
17. [Prevention of lactic acidosis due to metformin intoxication in contrast media nephropathy].
Landewé-Cleuren S; van Zwam WH; de Bruin TW; de Haan M
Ned Tijdschr Geneeskd; 2000 Sep; 144(40):1903-5. PubMed ID: 11045136
[TBL] [Abstract][Full Text] [Related]
18. Metformin-associated lactic acidosis following acute kidney injury. Efficacious treatment with continuous renal replacement therapy.
Dichtwald S; Weinbroum AA; Sorkine P; Ekstein MP; Dahan E
Diabet Med; 2012 Feb; 29(2):245-50. PubMed ID: 21977945
[TBL] [Abstract][Full Text] [Related]
19. Metformin-associated lactic acidosis: case reports and literature review.
Chang CT; Chen YC; Fang JT; Huang CC
J Nephrol; 2002; 15(4):398-402. PubMed ID: 12243370
[TBL] [Abstract][Full Text] [Related]
20. Metformin-associated lactic acidosis in patients with renal impairment solely due to drug accumulation?
Runge S; Mayerle J; Warnke C; Robinson D; Roser M; Felix SB; Friesecke S
Diabetes Obes Metab; 2008 Jan; 10(1):91-3. PubMed ID: 18095950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
